Matthew Spear, M.D.

Chief Medical Officer

30+ years of experience in oncology and gene therapy research and development, combining deep scientific expertise with functional leadership across both academic and industry roles. ‍

0
years of experience
0
years at DHCG

Matthew

's Service Domains

Clinical

Regulatory

Nonclinical

Business Analytics

About

Matt

Typical Client Projects
Selected Publications
Certifications
Industry Affiliations
Other Noteworthy Accomplishments
Selected Experience
Education
North America
C-Suite
Consulting Team
Clinical
Regulatory
Nonclinical
Business Analytics
Primary cells and tissues
iPSCs, ESCs (incl. gene-modified)
HSCs, MSCs (incl. gene-modified)
T cells (aβ, γδ, Treg), TILs, NK cells, B cells, DCs (incl. gene-modified)
Viral gene delivery (LVVs, AdVs, AAVs, RVs)
Non-viral gene delivery (mRNA, exosomes, LNPs, etc.)
Gene editing (CRISPR/Cas, ZFN, TALEN, base editors, etc.)
Dark Horse Consulting
Dark Horse Consulting